Corrie, PG, Marshall, A, Nathan, PD, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, CG, Marples, M, Danson, SJ et al (show 28 more authors)
(2019)
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial (vol 29, pg 1843, 2018).
ANNALS OF ONCOLOGY, 30 (12).
pp. 2013-2014.
Text
Adjuvant bevacizumab for melanoma patients at high risk of recurrence survival analysis of the AVAST-M trial.pdf - Published version Download (816kB) | Preview |
Official URL: http://dx.doi.org/10.1093/annonc/mdz237
Abstract
In the original article, there was an error in Figure 3. The figure has now been corrected as below in the online version of the article.
Item Type: | Article |
---|---|
Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology |
Depositing User: | Symplectic Admin |
Date Deposited: | 22 Dec 2021 09:19 |
Last Modified: | 15 Mar 2024 17:20 |
DOI: | 10.1093/annonc/mdz237 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3145823 |
Dimensions
Altmetric
Share
CORE (COnnecting REpositories)